| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 12/31/2008 | CN101333180A Method for preparing levetiracetam intermediate |
| 12/31/2008 | CN100447151C Peptide boronic acids useful in making salts thereof |
| 12/31/2008 | CN100447132C Method for the continuous production of n-methyl-2-pyrrolidone (NMP) |
| 12/31/2008 | CA2691849A1 Kallikrein 7 modulators |
| 12/31/2008 | CA2690553A1 Method for preparing fmoc - based hydrolysable linkers |
| 12/31/2008 | CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 12/31/2008 | CA2687557A1 Polyfunctional fullerene c60 amino acid derivatives |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470785 Oxidatively cyclizing a tetrahydrobilene compound in an organic solvent in the presence of a base, an oxidant and a metal salt and optionally displacing metal M to create a free base chlorin |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
| 12/25/2008 | US20080318813 Dispersant reaction product with antioxidant capability |
| 12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
| 12/25/2008 | US20080317662 Molten Salts, Method of Their Production and Process for Generating Hydrogen Peroxide |
| 12/24/2008 | WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders |
| 12/24/2008 | WO2008078341A3 Stable pharmaceutical formulations of atorvastatin magnesium salt |
| 12/24/2008 | WO2008076754A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 12/24/2008 | EP2006284A1 Dicyclooctane derivates, preparation processes and medical uses thereof |
| 12/24/2008 | EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2008 | EP2004600A1 Iap bir domain binding compounds |
| 12/24/2008 | EP2004599A2 Process for the preparation of an n-alkyl lactam with improved colour quality |
| 12/24/2008 | EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/24/2008 | EP1554274B1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 12/24/2008 | CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds |
| 12/24/2008 | CN101331115A Derivatives for modulation of ion channels |
| 12/24/2008 | CN101328136A Aminoacid acidamide compounds and preparation thereof |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/23/2008 | US7468444 Crystalline polymorphic dosage forms of anticholesterol agents; statins; suspending atorvastatin hemi-calcium in water for 16 hours convert the atorvastatin hemi-calcium into Form I |
| 12/23/2008 | US7468443 central nervous system disorders; regenerating nervous systems |
| 12/23/2008 | US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety |
| 12/23/2008 | US7468393 Diarylsulfones as 5-HT2A antagonists |
| 12/23/2008 | US7468383 Proteasome inhibitors and methods of using the same |
| 12/23/2008 | US7468369 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 12/23/2008 | CA2492096C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/18/2008 | WO2008153958A2 Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | WO2008153091A1 Screening method |
| 12/18/2008 | WO2008152386A1 Furanose derivatives |
| 12/18/2008 | WO2008152260A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 12/18/2008 | WO2008130332B1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 12/18/2008 | WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| 12/18/2008 | US20080312466 New sterospecifc chemical intermediates for statin drugs as astatin side chain building block to allow for a convergent ssynthesis; monoethyl ester of (3R)-acetoxyglutaaric acid chloride; efficiency; |
| 12/18/2008 | US20080312457 Process |
| 12/18/2008 | US20080312456 Process for the synthesis of peptides containing a 4-hydroxy-proline substructure |
| 12/18/2008 | US20080312444 Process for Preparing Bicyclic Compounds |
| 12/18/2008 | US20080312432 Stabilizers for Use in Nvp Synthesis |
| 12/18/2008 | US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders |
| 12/18/2008 | US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080311164 contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants |
| 12/18/2008 | CA2694871A1 Chemical compounds |
| 12/18/2008 | CA2691239A1 Method for determining enantiomeric purity of darifenacin and intermediates |
| 12/18/2008 | CA2687721A1 Crystalline forms of (r)-1-{2-[4'-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | CA2686223A1 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 12/17/2008 | EP1773763B1 Lysine based compounds |
| 12/17/2008 | EP1542968B1 Process for preparing intermediates |
| 12/17/2008 | EP1417176B1 Substituted anthranilamides for controlling invertebrate pests |
| 12/17/2008 | CN101326163A Prolinamide derivatives as sodium channel modulators |
| 12/17/2008 | CN101326162A Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 12/17/2008 | CN101326161A Novel compounds |
| 12/17/2008 | CN101326154A Intermediate compounds for the preparation of statins |
| 12/17/2008 | CN101323584A Oxime ether aryl pyrrole compounds having insecticidal, acaricidal and antifungal bioactivity |
| 12/17/2008 | CN101323583A Synthetic method of 3-substituted-pyrrolidine derivates |
| 12/16/2008 | US7465813 Process for making 5-methyl-N-alkyl-2-pyrrolidone from alkyl amine(s) and levulinic acid |
| 12/16/2008 | US7465812 neuroprotecting and preserving cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia |
| 12/16/2008 | US7465806 N-(1-alkyl-4-piperidinyl)-2-pyrrolecarboxamides, e.g., 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-pyrrole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide; treating vascular restenosis following angioplasty |
| 12/16/2008 | US7465751 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 12/16/2008 | US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives |
| 12/11/2008 | WO2008150231A1 New heterocyclic compounds for treatment of respiratory, airway or inflammatory disorders |
| 12/11/2008 | WO2008148799A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/11/2008 | WO2008148790A1 Anti -inflammatory substituted cyclobutenedione compounds |
| 12/11/2008 | WO2008148689A1 Prolinamide derivatives as nk3 antagonists |
| 12/11/2008 | WO2008008398A3 Oxime compounds and the use thereof |
| 12/11/2008 | US20080306283 Process For Production of Aralkyloxypyrrolidine Derivative |
| 12/11/2008 | US20080306282 Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-HeptanoicAcid Calcium Salt (2:1) |
| 12/11/2008 | US20080306281 Novel compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of alpha-perfluoroalkylamine compounds |
| 12/11/2008 | US20080306275 Novel heteroaryl derivative |
| 12/11/2008 | US20080306258 Cyclopropane compounds and pharmaceutical use thereof |
| 12/11/2008 | US20080306230 Composition and Associated Method |
| 12/11/2008 | US20080306123 Novel compounds |
| 12/11/2008 | US20080306122 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; depression or a mood disorder ; modulation of use-dependent voltage-gated sodium channels |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080305986 Multimers of Peptides |
| 12/11/2008 | US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof |
| 12/11/2008 | CA2690091A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/11/2008 | CA2689692A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/11/2008 | CA2689581A1 Anti -inflammatory substituted cyclobutenedione compounds |
| 12/11/2008 | CA2689560A1 Prolinamide derivatives as nk3 antagonists |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
| 12/10/2008 | EP2000461A1 Crystalline forms of atorvastatin |
| 12/10/2008 | EP2000126A1 Hair dyeing composition |
| 12/10/2008 | EP2000125A2 Hair dyeing composition |
| 12/10/2008 | EP1999124A1 Glycosidase inhibitors and methods of synthesizing same |
| 12/10/2008 | EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/10/2008 | EP1756052B1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 12/10/2008 | EP1419160B1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |